Evaluating the value of supportive medical apps during the treatment for breast cancer
Young-Afat et al, 2014; Amsterdam EBCC9.
First place in the Digital Health Masterclass Challenge 2013
Px HealthCare won first place in the Digital Health Masterclass Challenge held by Janssen Healthcare Innovation and Johnson & Johnson Innovation.
NHS Innovation Accelerator
Anne joined the NHS Innovation Accelerator (NIA) from the Netherlands … Continue reading "NHS Innovation Accelerator"
Optimising oncology outcomes with a mobile app for breast cancer patients: A qualitative evaluation.
2016 NCRI Conference
Is there value in using patient recorded outcome measures to improve toxicity management patients receiving chemotherapy for breast cancer?
2017 Annual British Oncology Pharmacy Association Symposium
OWise receives top prize in Scotland’s Cancer Innovation Challenge
OWise was one of the projects selected to win the finals and progress to phase two of the Cancer Innovation Challenge!
OWise wins top NESTA Healthier Lives Data Fund Prize
Px Healthcare won £60,000 in funding from the Scottish Government to keep developing their products and scale them across Scotland.
Evaluating a digital tool for supporting breast cancer patients: a randomized controlled trial protocol (ADAPT)
Lidington et al., 2020; BMC. OWise is being assessed by the randomised clinical trial ADAPT at the Royal Marsden NHS Foundation Trust. Find out more here:
Evaluating mobile applications for Breast Cancer in Germany: A systematic review
A systematic review that evaluated if breast cancer apps can support patients, whereby the OWise app received the highest score.
Patients’ and Health Care Providers’ Opinions on a Supportive Health App During Breast Cancer Treatment: A Qualitative Evaluation
Young-Afat et al., 2016; JMIR Cancer. Independent study analysed OWise app. Read more to know what the study found!